Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

The Lancet Neurology - Tập 7 Số 12 - Trang 1091-1098 - 2008
Josep Dalmau1, Amy J. Gleichman2, Ethan G. Hughes2, Jeffrey Rossi1, Xiaoyu Peng2, Meizan Lai1, Scott Dessain3, Myrna R. Rosenfeld1, Rita J. Balice‐Gordon2, David R. Lynch4,5
1Dept of Neurology, University of Pennsylvania, Philadelphia, PA, USA
2Department of Neuroscience, University of Pennsylvania, Philadelphia, PA, USA
3Lankenau Institute for Medical Research, Wynnewood PA, USA
4Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA
5Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Lynch, 1994, N-methyl-D-aspartate receptors: different subunit requirements for binding of glutamate antagonists, glycine antagonists, and channel-blocking agents, Mol Pharmacol, 45, 540

Coyle, 2006, Glutamate and schizophrenia: beyond the dopamine hypothesis, Cell Mol Neurobiol, 26, 365, 10.1007/s10571-006-9062-8

Waxman, 2005, N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease, Neuroscientist, 11, 37, 10.1177/1073858404269012

Lau, 2007, NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders, Nat Rev Neurosci, 8, 413, 10.1038/nrn2153

Dalmau, 2007, Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma, Ann Neurol, 61, 25, 10.1002/ana.21050

Sansing, 2007, A patient with encephalitis associated with NMDA receptor antibodies, Nat Clin Pract Neurol, 3, 291, 10.1038/ncpneuro0493

Kataoka, 2008, Paraneoplastic encephalitis associated with ovarian teratoma and N-methyl-D-aspartate receptor antibodies, Eur J Neurol, 15, e5, 10.1111/j.1468-1331.2007.02005.x

Iizuka, 2008, Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal, Neurology, 70, 504, 10.1212/01.wnl.0000278388.90370.c3

Seki, 2008, Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis, J Neurol Neurosurg Psychiatry, 79, 324, 10.1136/jnnp.2007.136473

van Swieten, 1988, Interobserver agreement for the assessment of handicap in stroke patients, Stroke, 19, 604, 10.1161/01.STR.19.5.604

Folstein, 1975, “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res, 12, 189, 10.1016/0022-3956(75)90026-6

Meddows, 2001, Identification of molecular determinants that are important in the assembly of N-methyl-D-aspartate receptors, J Biol Chem, 276, 18795, 10.1074/jbc.M101382200

Elmariah, 2005, Astrocytes regulate inhibitory synapse formation via Trk-mediated modulation of postsynaptic GABAA receptors, J Neurosci, 25, 3638, 10.1523/JNEUROSCI.3980-04.2005

Wu, 2007, Fyn-mediated phosphorylation of NR2B Tyr-1336 controls calpain-mediated NR2B cleavage in neurons and heterologous systems, J Biol Chem, 282, 20075, 10.1074/jbc.M700624200

Tibbling, 1977, Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values, Scand J Clin Lab Invest, 37, 385, 10.3109/00365517709091496

Newsom-Davis, 2004, Lambert-Eaton myasthenic syndrome, Rev Neurol (Paris), 160, 177, 10.1016/S0035-3787(04)70888-7

Gianani, 1996, Viruses, cytokines, antigens, and autoimmunity, Proc Natl Acad Sci USA, 93, 2257, 10.1073/pnas.93.6.2257

Fairweather, 2005, Viruses as adjuvants for autoimmunity: evidence from Coxsackievirus-induced myocarditis, Rev Med Virol, 15, 17, 10.1002/rmv.445

Huerta, 2006, Immunity and behavior: antibodies alter emotion, Proc Natl Acad Sci USA, 103, 678, 10.1073/pnas.0510055103

Kowal, 2004, Cognition and immunity; antibody impairs memory, Immunity, 21, 179, 10.1016/j.immuni.2004.07.011

Manahan-Vaughan, 2008, A single application of MK801 causes symptoms of acute psychosis, deficits in spatial memory, and impairment of synaptic plasticity in rats, Hippocampus, 18, 125, 10.1002/hipo.20367

McCarron, 1981, Acute phencyclidine intoxication: incidence of clinical findings in 1,000 cases, Ann Emerg Med, 10, 237, 10.1016/S0196-0644(81)80047-9

Ilkiw, 1996, The effect of intravenous administration of variable-dose midazolam after fixed-dose ketamine in healthy awake cats, J Vet Pharmacol Ther, 19, 217, 10.1111/j.1365-2885.1996.tb00041.x

Marco, 1992, A ketamine-induced rat model of tardive dyskinesia, Prog Neurobiol, 38, 571, 10.1016/0301-0082(92)90042-D

Hallett, 2005, Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's disease, Neuropharmacology, 48, 503, 10.1016/j.neuropharm.2004.11.008

Taittonen, 1998, The effect of clonidine or midazolam premedication on perioperative responses during ketamine anesthesia, Anesth Analg, 87, 161, 10.1213/00000539-199807000-00034

Heinz, 2006, Is atropine needed with ketamine sedation? A prospective, randomised, double blind study, Emerg Med J, 23, 206, 10.1136/emj.2005.028969

Forrest, 1994, Curran T. Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death, Neuron, 13, 325, 10.1016/0896-6273(94)90350-6

Hauser, 2008, B-cell depletion with rituximab in relapsing-remitting multiple sclerosis, N Engl J Med, 358, 676, 10.1056/NEJMoa0706383

Molloy, 2007, Primary angiitis of the central nervous system, Curr Treat Options Neurol, 9, 169, 10.1007/BF02938406